Drug-pricing – medicarereport.org

Tuesday, December 3, 2024

Latest:

CMS Health Care Finance Health Care Redesign Part D/Prescription Drugs

Eileen Cook August 16, 2023August 16, 2023 0 Comments CMS, Drug-pricing, Medicare Drug Price Negotiation Program, Medicare Part D

The 10 drugs that CMS might wrangle into negotiations

(By Paige Twenter for Becker’s Hospital Review) CMS plans to soon release its list of 10 drugs that are up

Health Care Finance Health Care Redesign Part D/Prescription Drugs

Eileen Cook May 25, 2023May 25, 2023 0 Comments Affordable Medicine, Drug-pricing, Healthcare Costs

This Panel Will Decide Whose Medicine to Make Affordable. Its Choice Will Be Tricky

(By Markian Hawryluk for KFF Health News) Catherine Reitzel’s multiple sclerosis medication costs nearly $100,000 a year. Kris Garcia relies

FDA Health Care Finance Legislative Update Part D/Prescription Drugs

Eileen Cook May 11, 2023 0 Comments Drug-pricing, Legislation, PBM Industry, pharmaceuticals

PBMs, the Brokers Who Control Drug Prices, Finally Get Washington’s Attention

(By Arthur Allen for KFF Health News) For two decades, patients and physicians eagerly awaited a lower-cost version of the

Affordable Care Act (ACA)Employer Healthcare Health Care Redesign Health Insurance Legislative Update Part D/Prescription Drugs

Eileen Cook December 15, 2022December 15, 2022 0 Comments Drug-pricing, Employer Health Insurance, Higher out-of-pocket expense, Inflation Reduction Act of 2022, medicare

How Medicare drug pricing changes could affect commercial plans: 3 things to know

(By Rylee Wilson for Becker’s Hospital Review) The drug-pricing provisions of the Inflation Reduction Act only apply directly to Medicare,